Genmab Appoints Annarie Lyles as Head of Business Development
News Jan 04, 2006
Genmab A/S has announced the appointment of Annarie Lyles, Ph.D. as Head of Business Development with effect from January 1, 2006.
Dr. Lyles was previously appointed Vice President, Business Development at Genmab in June 2005.
Dr. Lyles replaces Dr. Ernst Schweizer, who has retired from his position as Head of Business Development. Dr. Schweizer remains a member of the Genmab Board of Directors.
CRISPR Screening Reveals Sickle Cell Disease TargetNews
A key signaling protein, known as heme-regulated inhibitor (HRI), has been identified as a potential therapeutic target for the development of drugs to treat sickle cell disease, using a CRISPR screening approach.READ MORE
DNA Methylation Related to Liver Disease in Obese PatientsNews
DNA methylation implicated in initiation of liver fibrosis in non-alcoholic fatty liver diseaseREAD MORE
UCL Technology Fund Investment MeiraGTx Raises $75 Million in IPONews
MeiraGTx Holdings plc raised $75 million of gross proceeds upon close of the company’s initial public offering (IPO).READ MORE
International Conference on Neurooncology and Neurosurgery
Sep 17 - Sep 18, 2018